- Dr Amanda Edgley obtained her PhD from Monash University in 2001, after which she undertook a post-doctoral position at AstraZeneca Pharmaceuticals in Sweden, as part of an NHMRC Industry Fellowship. Dr Edgley currently holds a joint position as a senior research fellow in the Biomedical Translational Research Group and as Academic Co-ordinator of Research Training at Eastern Hill Academic Precinct. Her current research interests focus on developing and evaluating novel compounds for the treatment of pathological inflammation and fibrosis in diabetic and non-diabetic kidney, heart and eye disease. Inflammation and fibrosis underlie the decline in organ function in many cardiovascular conditions. Dr Edgley has over 17 years’ experience in the field of integrative cardiovascular physiology and pharmacology, with technical expertise in vivo analysis of vascular, cardiac and renal function. Dr Edgley has also used synchrotron radiation microangiography techniques to study aspects of coronary microvascular function in health and disease and has utilised synchrotron short angle x-ray scattering (SAXS) to investigate regulation of myocardial cross bridge function in disease.